YukiYoshida

Of Counsel

Tokyo + 81.3.6744.1634

Connect:

Share

Yuki Yoshida has more than 10 years of experience representing clients in domestic and cross-border M&A, joint ventures, private equity, and other commercial transactions. He represents buyers, sellers, targets, and financial advisors in domestic and cross-border stock and asset acquisitions, divestitures, restructuring, and strategic alliances. Based on his broad knowledge and experience, Yuki provides clients with attractive commercial solutions for complex legal issues.

Yuki has represented clients in a wide variety of industries, including automotive, chemicals, energy, financial services, health care, manufacturing, pharmaceuticals, and technology. His recent experiences include TDK's $1.3 billion acquisition of InvenSense, Inc. as well as Tonen General Sekiyu's business integration with JX Group.

Yuki also advises clients on corporate governance, securities compliance and regulatory matters, as well as antitrust matters. Recently, his practice also has focused on the legal issues relating to blockchain technologies, and he has written various articles relating to this technology.

Yuki is a member of the Japanese Bar Association and the Daini Tokyo Bar Association. He is actively involved in various pro bono activities. In particular, he regularly serves as a court-appointed counsel for indigent defendants.

Experience

  • Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholdersJones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.
  • Avient to acquire DSM Protective Materials businessJones Day is advising Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable material solutions, in its $1.485 billion purchase of Koninklijke DSM N.V.’s protective materials business, a leading specialty engineered materials business built around the invention of Dyneema®, the world’s strongest fiber.
  • Deezer merges with and into I2PO S.A.Jones Day is advising Deezer S.A. in the context of the proposed SPAC transaction whereby Deezer S.A. would be merged with and into I2PO S.A., a French SPAC listed on the professional segment of the regulated market of Euronext Paris and the related PIPE financing.
  • Ansys, Inc. acquires OnScale, Inc.Jones Day is advising Ansys, Inc. in the acquisition of OnScale, Inc., a cloud simulation provider.
  • Riverside sells Y InternationalJones Day advised The Riverside Company in the sale of Y International, Inc., a Japanese bicycle retailer, to Daiwa PI Partners Co., Ltd.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health on the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • EagleTree Capital acquires IntegreonJones Day advised EagleTree Capital in connection with the acquisition and financing of Integreon, a leading global managed services provider, from NewQuest Capital Partners.
  • Furukawa Electric and Superior Essex global joint venture finalizedJones Day advised Furukawa Electric Co., Ltd. in its finalization of a global joint venture with Superior Essex Inc.
  • Investment management firm and its affiliated funds recapitalize technology firmJones Day advised an investment management firm and its affiliated funds in connection with a strategic recapitalization of a technology firm.
  • Koch Industries acquired remaining equity stake in InforJones Day advised Koch Equity Development LLC, a subsidiary of Koch Industries, Inc., on the purchase of the remaining equity stake held by Golden Gate Capital in Infor, a global leader in business cloud software specialized by industry.
  • J.F. Lehman acquires Integrated Global ServicesJones Day advised long-standing client J.F. Lehman & Company, a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government, and environmental sectors, in the acquisition and related financing of Integrated Global Services, Inc. ("IGS").
  • OMRON Nohgata sells 80 percent stake to AdvantechJones Day advised OMRON Corporation in the sale of an 80 percent interest in OMRON Nohgata to Advantech.
  • Hitachi acquires Mitsubishi Electric's particle therapy system businessJones Day advised Hitachi, Ltd. in its acquisition of the particle therapy system business from Mitsubishi Electric Corporation.
  • Orocobre Limited secures A$361 million funding through private placement and underwritten accelerated entitlement offerJones Day represented Orocobre Limited, a leading lithium chemicals producer, in connection with its A$361 million capital raising, comprising of a A$282 million private placement to Toyota Tsusho Corporation and an underwritten entitlement offer raising A$79 million.
  • Cardinal Health acquires leading patient product portfolio from Medtronic for $6.1 billionJones Day advised Cardinal Health on the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash.
  • Reynolds American acquired by British American Tobacco Plc in deal valued at $49 billionJones Day advised Reynolds American Inc. ("RAI") regarding the acquisition by British American Tobacco, p.l.c. ("BAT") of 57.8 percent of the outstanding shares of RAI not owned by BAT and its affiliates in a transaction valued at $49 billion.
  • TDK acquires InvenSense for $1.3 billionJones Day advised TDK Corporation in its $1.3 billion acquisition of InvenSense, Inc.
  • TonenGeneral Sekiyu combines with JX GroupJones Day advised TonenGeneral Sekiyu K.K. in connection with the business integration with JX Group, which forms the largest oil refiner in Japan.
  • Sumitomo Dainippon Pharma acquires Tolero Pharmaceuticals, Inc.Jones Day advised Sumitomo Dainippon Pharma Co. Ltd., a leading pharmaceutical company based in Japan, in its acquisition of Tolero Pharmaceuticals, Inc.
  • MAHLE sells its industrial filtration business to Filtration GroupJones Day advised MAHLE in the sale of its industrial filter business to Filtration Group Corporation.
    • View All

    February 2022 ニュースレター

    Global Legal Update Vol. 76 | 2022年2月号

    August 2021 ニュースレター

    Global Legal Update Vol. 70 | 2021年8月号

    April 2021 Jones Day Publications

    Global Legal Update Vol. 66 | 2021年4月号

    March 2021 Jones Day Publications

    Global Legal Update Vol. 65 | 2021年3月号

    February 2021 Jones Day Publications

    Global Legal Update Vol. 64 | 2021年2月号

    January 2021 Jones Day Publications

    Global Legal Update Vol. 63 | 2021年1月号

    November 2020 Newsletters

    Japan Legal Update Vol. 53 | Autumn 2020

    October 2020 Jones Day Publications

    Global Legal Update Vol. 60 | 2020年10月号

    August 2020 Jones Day Publications

    Global Legal Update Vol. 58 | 2020年8月号

    August 2020 Newsletters

    Japan Legal Update Vol. 52 I Summer 2020
    View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.